Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Apr;71(4):809–815. doi: 10.1172/JCI110834

Effect of Captopril on Uterine Blood Flow and Prostaglandin E Synthesis in the Pregnant Rabbit

Thomas F Ferris 1, Edward K Weir 1
PMCID: PMC436937  PMID: 6339559

Abstract

Captopril, 5 mg/kg, administered to pregnant rabbits caused a reduction in mean arterial pressure (MAP) from 106±2 to 87±2 mmHg (P<0.01) without change in cardiac output or renal blood flow. Uterine blood flow fell from 31.9±2.5 to 21.3±3.4 ml/min (P<0.01) as uterine vein prostaglandin E series level (PGE) decreased from 127±23 ng/ml to 26±8 ng/ml (P<0.01). Saralasin also caused a reduction in MAP from 110±5 to 92±4.3 (P<0.01), a reduction in uterine blood flow from 28.8±1.6 to 21.8±1.7 ml/min (P<0.01) as uterine vein PGE decreased from 121.3±14.4 to 63.5±14.2 ng/ml (P<0.01). Plasma renin activity (PRA) was higher in the uterine vein, 11±3 ng/ml per h, than peripheral vein, 6±1.6 ng/ml per h, (P<0.05), before Captopril and rose in the uterine vein to 90±19 ng/ml per h (P<0.01) as peripheral vein PRA rose to 62±15 ng/ml per h (P<0.05) after Captopril. After saralasin uterine vein PRA rose from 4.6±1.5 to 14.8±6.3 ng/ml per h (P<0.05) and peripheral vein PRA rose from 3.7±1 to 6.5±2.1 (P<0.05).

Reducing MAP with MgSO4 from 98±4 to 70±2 (P<0.01) caused a significant fall in cardiac output from 695±33 to 588±49 (P<0.01) without change in renal or uterine blood flow. Uterine vein PGE concentration also did not change significantly following MgSO4; 80±22 ng/ml before and 60±27 ng/ml (NS) during the administration of MgSO4.

Chronic administration of Captopril in doses of either 2.5 or 5.0 mg/kg per d from the 15th d of gestation caused an 86% fetal mortality at the lower and a 92% fetal mortality at the higher dose of the drug.

These experiments point to the importance of uterine PGE synthesis in maintenance of uterine blood flow and fetal survival during pregnancy and suggest that uterine PGE synthesis is dependent upon angiotensin II. Synthesis of uterine renin and PGE may be necessary for maintenance of uterine blood flow and fetal survival during pregnancy.

Full text

PDF
809

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASSALI N. S., HOLM L. W., SEHGAL N. Regional blood flow and vascular resistance of the fetus in utero. Action of vasoactive drugs. Am J Obstet Gynecol. 1962 Mar 15;83:809–817. doi: 10.1016/0002-9378(62)90705-6. [DOI] [PubMed] [Google Scholar]
  2. Albertini R., Seino M., Scicli A. G., Carretero O. A. Uteroplacental renin in regulation of blood pressure in the pregnant rabbit. Am J Physiol. 1980 Aug;239(2):H266–H271. doi: 10.1152/ajpheart.1980.239.2.H266. [DOI] [PubMed] [Google Scholar]
  3. Bay W. H., Ferris T. F. Factors controlling plasma renin and aldosterone during pregnancy. Hypertension. 1979 Jul-Aug;1(4):410–415. doi: 10.1161/01.hyp.1.4.410. [DOI] [PubMed] [Google Scholar]
  4. Blair-West J. R., Coghlan J. P., Denton D. A., Funder J. W., Scoggins B. A., Wright R. D. Inhibition of renin secretion by systemic and intrarenal angiotensin infusion. Am J Physiol. 1971 May;220(5):1309–1315. doi: 10.1152/ajplegacy.1971.220.5.1309. [DOI] [PubMed] [Google Scholar]
  5. Erdös E. G. The kinins. A status report. Biochem Pharmacol. 1976 Jul 15;25(14):1563–1569. doi: 10.1016/0006-2952(76)90465-2. [DOI] [PubMed] [Google Scholar]
  6. Everett R. B., Worley R. J., MacDonald P. C., Gant N. F. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endocrinol Metab. 1978 Jun;46(6):1007–1010. doi: 10.1210/jcem-46-6-1007. [DOI] [PubMed] [Google Scholar]
  7. Ferris T. F., Gorden P., Mulrow P. J. Rabbit uterus as a source of renin. Am J Physiol. 1967 Mar;212(3):698–702. doi: 10.1152/ajplegacy.1967.212.3.698. [DOI] [PubMed] [Google Scholar]
  8. Ferris T. F., Stein J. H., Kauffman J. Uterine blood flow and uterine renin secretion. J Clin Invest. 1972 Nov;51(11):2827–2833. doi: 10.1172/JCI107105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Franklin G. O., Dowd A. J., Caldwell B. V., Speroff L. The effect of angiotensin-II intravenous infusion on plasma renin activity and prostaglandins A, E, and F levels in the uterine vein of the pregnant monkey. Prostaglandins. 1974 May 25;6(4):271–280. doi: 10.1016/s0090-6980(74)80001-8. [DOI] [PubMed] [Google Scholar]
  10. Frölich J. C., Wilson T. W., Sweetman B. J., Smigel M., Nies A. S., Carr K., Watson J. T., Oates J. A. Urinary prostaglandins. Identification and origin. J Clin Invest. 1975 Apr;55(4):763–770. doi: 10.1172/JCI107987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gallery E. D., Saunders D. M., Hunyor S. N., Györy A. Z. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Br Med J. 1979 Jun 16;1(6178):1591–1594. doi: 10.1136/bmj.1.6178.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gant N. F., Daley G. L., Chand S., Whalley P. J., MacDonald P. C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973 Nov;52(11):2682–2689. doi: 10.1172/JCI107462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerber J. G., Payne N. A., Murphy R. C., Nies A. S. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest. 1981 Mar;67(3):632–636. doi: 10.1172/JCI110077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gill J. R., Jr Bartter's syndrome. Annu Rev Med. 1980;31:405–419. doi: 10.1146/annurev.me.31.020180.002201. [DOI] [PubMed] [Google Scholar]
  15. Gorden P., Ferris T. F., Mulrow P. J. Rabbit uterus as a possible site of renin synthesis. Am J Physiol. 1967 Mar;212(3):703–706. doi: 10.1152/ajplegacy.1967.212.3.703. [DOI] [PubMed] [Google Scholar]
  16. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  17. Keeton T. K., Campbell W. B. The pharmacologic alteration of renin release. Pharmacol Rev. 1980 Jun;32(2):81–227. [PubMed] [Google Scholar]
  18. Kimbrough H. M., Jr, Vaughan E. D., Jr, Carey R. M., Ayers C. R. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res. 1977 Feb;40(2):174–178. doi: 10.1161/01.res.40.2.174. [DOI] [PubMed] [Google Scholar]
  19. Lewis P. J., Boylan P., Friedman L. A., Hensby C. N., Downing I. Prostacyclin in pregnancy. Br Med J. 1980 Jun 28;280(6231):1581–1582. doi: 10.1136/bmj.280.6231.1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mimran A., Guiod L., Hollenberg N. K. The role of angiotensin in the cardiovascular and renal response to salt restriction. Kidney Int. 1974 May;5(5):348–355. doi: 10.1038/ki.1974.50. [DOI] [PubMed] [Google Scholar]
  21. Rector J. B., Stein J. H., Bay W. H., Osgood R. W., Ferris T. F. Effect of hemorrhage and vasopressor agents on distribution of renal blood flow. Am J Physiol. 1972 May;222(5):1125–1131. doi: 10.1152/ajplegacy.1972.222.5.1125. [DOI] [PubMed] [Google Scholar]
  22. Redman C. W. Treatment of hypertension in pregnancy. Kidney Int. 1980 Aug;18(2):267–278. doi: 10.1038/ki.1980.135. [DOI] [PubMed] [Google Scholar]
  23. Shapiro S., Siskind V., Monson R. R., Heinonen O. P., Kaufman D. W., Slone D. Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. Lancet. 1976 Jun 26;1(7974):1375–1376. doi: 10.1016/s0140-6736(76)93026-9. [DOI] [PubMed] [Google Scholar]
  24. Speroff L., Haning R. V., Jr, Levin R. M. The effect of angiotensin II and indomethacin on uterine artery blood flow in pregnant monkeys. Obstet Gynecol. 1977 Nov;50(5):611–614. [PubMed] [Google Scholar]
  25. Swartz S. L., Williams G. H., Hollenberg N. K., Levine L., Dluhy R. G., Moore T. J. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest. 1980 Jun;65(6):1257–1264. doi: 10.1172/JCI109788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Symonds E. M., Stanley M. A., Skinner S. L. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968 Mar 23;217(5134):1152–1153. doi: 10.1038/2171152a0. [DOI] [PubMed] [Google Scholar]
  27. Turner G., Collins E. Fetal effects of regular salicylate ingestion in pregnancy. Lancet. 1975 Aug 23;2(7930):338–339. doi: 10.1016/s0140-6736(75)92778-6. [DOI] [PubMed] [Google Scholar]
  28. Venuto R. C., Cox J. W., Stein J. H., Ferris T. F. The effect of changes in perfusion pressure on uteroplacental blood flow in the pregnant rabbit. J Clin Invest. 1976 Apr;57(4):938–944. doi: 10.1172/JCI108370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Venuto R. C., O'Dorisio T., Stein J. H., Ferris T. F. Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit. J Clin Invest. 1975 Jan;55(1):193–197. doi: 10.1172/JCI107911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Venuto R. C., O'Dorisio T., Stein J. H., Ferris T. F. Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit. J Clin Invest. 1975 Jan;55(1):193–197. doi: 10.1172/JCI107911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weir R. J., Brown J. J., Fraser R., Kraszewski A., Lever A. F., McIlwaine G. M., Morton J. J., Robertson J. I., Tree M. Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet. 1973 Feb 10;1(7798):291–294. doi: 10.1016/s0140-6736(73)91540-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES